Amerindian women of the Brazilian Amazon and STD

Papanicolaou tests, PCR for HPV, C. trachomatis, HSV-1/2 and N. gonorrhoea, and Hybrid Capture II were performed for high- and low-risk HPV groups during screening for cervical cancer in 49 women of the Parakana tribe. Cytological diagnoses of HPV were suggested in three samples: PCR showed 12 (22.4%) cases of DNA positive HPV, 16 (1), 18 (2), 58 (3), 39 (1), 61 (1), 33 (1), 35 (1), unknown (2), and HCII analyzed 48 samples: 19 positive (39.58%) for the high-risk group and four (18.33%) for the low-risk group. The prevalence of HPV was 42.85% (p = 0.001) by molecular biology methods. The largest viral load was 1588.11 pg/ml for HPV 39 in a 16-year-old. PCR was positive for C. trachomatis and negative for HSV-1/2 and N. gonorrhoea. Parakana women present a high risk for the development of cervical cancer.

STD; High-risk HPV; Amerindian of the Amazonian; Prevention of cervical cancer

[1] Menezes R.C.: Report of the Sub-program of Health of the Parakana Program, 2003.

[2] Brito E.B., Menezes R.C., Martins S.J., Bastos M.G., Sousa A "Preliminary study on low trait genital infection cervical and epithelial dysplasia in women from the Parakana tribe of South America". Rev. Assoc. Med. Bras., 1996, 42, 11.

[3] Digene Brasil - Manual of Instructions. System of hybrid capture in microplaca of digene. Test for DNA-HPV, revised 02/2003.

[4] Benard H., Chan S., Brothers M., Ong C., Villa L.L., Delius H. et al.: "Identification an assessment of know and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment lengh polymorphisms, nucleotide sequence and phylogenetic algorithms". Journal Infect. Dis.,1994, 170, 1077.

[5] Jolly A.M., Orr P.H., Hammond G., Young T.K.: "Risk factors goes infection in women undergoing testing goes Chlamydia trachomatis and Neisseria gonorrhoeae in Manitoba, Canada". Sex. Transm. Dis., 1995, 22, 289.

[6] Kenney J.W.: "Ethnic differences in risk factors associated with genital human papillomavirus infections". J. Adv. Nurs., 1996, 23, 1221.

[7] Young T.K., Mcnicol P., Beauvaus J.: "Factors associated with human papillomavirus infection detected by polimerase chain reaction among urban Canadian aboriginal and non-aboriginal women [see comments]". Comment in: Sex Transm. Dis., 1998, 25, 55.

[8] Ong C.K., Bernard H.U., V仆la L.L.: "Identification of genomic sequences of three novel human papillomavirus sequences in cervical smears of amazonian indians [published erratum appears in J.I.D., 1996, 173, 516]". J. Infect. Dis., 1994, 170, 1086.

[9] Brito E.B., Villa L.L., Menezes R.C., Martins SJ.: "Human papillomavirus infection among women from a South American Indian Tribe". In: XIV FIGO, World Congress in Montreal, Canada, 1993.

[10] Boulanger J.C., Bauville A.N.D., Nasreddine T.H.E., Ghighi C., Sevestre H., Gondry J. et al.: "Epidemiology of HPV Infection in picardy and viral load", Abstract book. Eurogin, 2003, 105, SS6

[11] Brito E.B., Martins SJ., Menezes R.C.: "Human papillomaviruses in Amerindian women from Amazonian Brazilian". Epidemiol. Infect., 2002, 128, 485.

[12] Ho G.Y.F., Burk R.D., Klein S. et al.: "Persistent genital human papillomavirus infection the the risk factor goes persistent cervical dysplasia". J. Natl. Cancer Inst., 1995, 87, 1365.

[13] Buga G.A.: "Cancer awareness and risk factors among female University Student". East Afr. Med. J., 1998, 75, 411

[14] Franco E.L., Villa L., Rohan T., Ferenczy A., Petzl-Erler M., Matlashewski G.: "Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil". Ludwig-McGill Study Group. Rev. Panam Salud Publishes, 1999, 6, 223.

[15] Ferenczy T.H.E., Franco A.N.D., Arseneau J., Wright T.C., Richart R.M.: "Diagnostic performance of hybrid captures human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study". Am. J. Obstet Gynecol., 1996, 175 (3 pt 1), 651.

[16] Lorincz A.: "Portland study update". Eurogin 2003. Paris, April 13-16, 2003.

[17] Bisgaard K.: "A possible marker for diagnosis of cervical precancer- an alternative to HPV testing?". Final program and Abstracts book (SS5). Eurogin, Paris, France, 2003, 103.

[18] Sankaranarayana R.: "Emerging issues cervical in cancer screening: developing countries: He/she SAW". Abstracts book. Eurogin, Paris, 2003, 95.

[19] Jacinth C.，印ho Almeida G., Maldonado P.: "HPV - Genital Infection Feminine and Masculine". I" edition, Rio de Janeiro, Revinter, 1994.

[20] Koskela P., Anttila T., Bjorge T., Brunsvig T.H.E., Dillner J., Hakama M., Hakulinem T. et al.: "Chlamydia trachomatis infection the the risk factor goes invasive cervical cancer". Int. Cancer, 2000, 85, 35.

[21] Judlin P.: "Emerging issues of non viral STIS: complications and management of chronic diseases: addressing the issue". Abstracts Book, Eurogin, Paris, 2003, 82.

[22] Villa L.L.: "Human papillomaviruses and cervical cancer". Cancer Adv. Cancer Res., 1997, 71, 321.

[23] Vogin, Gay D.: "The study was funded by Merck & Company which manufactures the vaccine". 44th Interscience Conference on Antimicrobial Agents & Chemotherapy (ICAAC). Abstract 3741, presented in 2004.